Living with Lymphoma
Living with Lymphoma provides the latest information about lymphoma diagnosis, current treatment options, and patient support issues.
On the day of the program, you will have access to an interactive attendee hub where you can watch live educational sessions and network with other attendees and exhibitors.
All lymphoma patients and care partners are welcome to join!
Date: Saturday, April 19, 2025
Time: 9:00 AM – 1:30 PM ET
* Please note this is a virtual program.
You may also register by calling or emailing our Helpline at 800-500-9976 or lymphoma@lymphoma.org.
Program Agenda
Program Agenda – Click Here
April 19, 2025
9:00 AM-9:30 AM ET – Explore Virtual Space
9:30 AM-11:00 AM ET – Introductory Session – Virtual
Lymphoma Overview & Navigating Clinical Trials
Priyanka Pophali, MD, University of Wisconsin
Krish Patel, MD, Sarah Cannon Research Institute
11:00 AM-11:15 AM ET – Networking Break
11:15 AM ET – Disease-Specific Educational Sessions Including Q&A
Newly Diagnosed Aggressive B-cell Non-Hodgkin Lymphomas
Reem Karmali, MD, MS, Northwestern University
Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Adam Kittai, MD, Mount Sinai
Follicular Lymphoma and Marginal Zone Lymphoma
Naren Epperla, MD, MS, FACP, University of Utah
Hodgkin Lymphoma
Natalie Grover, MD, University of North Carolina
Mantle Cell Lymphoma
Alexey Danilov, MD, PhD, City of Hope
T-Cell Lymphomas (PTCL and CTCL)
Swaminathan P. Iyer, MD, MD Anderson Cancer Center
Waldenström Macroglobulinemia
Shayna Sarosiek, MD, Dana-Farber Cancer Institute
12:15 PM-12:30 PM ET – Networking Break
12:30 PM ET – Special Topic Sessions Including Q&A – Choose One
Nutrition – Speaker TBA
Side Effect Management and Dose Modifications
Betsy Fuchsteiner, RN, BSN, OCN, University of Wisconsin
Maggie Schenkat, PharmD, University of Wisconsin
Supporting Your Mental Health
Samuel Jonas, MSW, LSWAIC, Swedish Cancer Institute
Physical Activity and Exercise – Speaker TBA
Program Chairs
Priyanka Pophali, MD
University of Wisconsin
Krish Patel, MD
Sarah Cannon Research Institute
This program is for patients and survivors, care partners and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.
Disclaimer: The Lymphoma Research Foundation is a national nonprofit organization based in the United States (U.S.) with educational programs and resources which are intended for a U.S. based audience. These programs and resources are intended for educational purposes only and are not a substitute for medical advice. Individuals who use Foundation programs and services are advised to consult a medical professional for medical advice, diagnoses, or treatment. Foundation programs and resources address available lymphoma/CLL treatments in the United States and information on drug approvals by the U.S. Food and Drug Administration (FDA).
The Foundation does not endorse any treatments, products, or services mentioned in its resources. The information provided is for informational purposes only and should not be considered as an endorsement. The Foundation shall not be liable for any direct, indirect, incidental, special, consequential, or punitive damages arising out of the use of its programs and resources, to the extent permitted by law. You assume full responsibility for any actions taken based on the information provided.
For individuals outside of the U.S. seeking information, the Foundation recommends the Lymphoma Coalition. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non-U.S.-based audiences. Additional information can be found by visiting their website at https://lymphomacoalition.org.
All content provided by the Foundation is protected by intellectual property laws. You may not reproduce, distribute, or otherwise use the content without the Foundation’s prior written consent.
Program Supporters
This activity is supported by educational grants from: